Ifp Advisors, Inc Rigel Pharmaceuticals Inc Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Rigel Pharmaceuticals Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 1,000 shares of RIGL stock, worth $13,700. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,000

Previous 1,000 -0.0%

Holding current value

$13,700

Previous $1,000 700.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 30, 2024	SELL	$1.12 - $1.57 $1,092 - $1,530	-975 Reduced 49.37%	1,000 $1,000
Q2 2023 Aug 04, 2023	SELL	$1.12 - $1.82 $41 - $67	-37 Reduced 1.84%	1,975 $2,000
Q1 2023 Apr 18, 2023	SELL	$1.25 - $2.0 $10 - $16	-8 Reduced 0.4%	2,012 $2,000
Q4 2022 Feb 07, 2023	SELL	$0.67 - $11.9 $4 - $83	-7 Reduced 0.35%	2,020 $8,000
Q2 2022 Sep 06, 2022	BUY	$0.67 - $3.19 $1,358 - $6,466	2,027 New	2,027 $8,000
Q2 2022 Aug 12, 2022	SELL	$0.67 - $3.19 $1,358 - $6,466	-2,027 Closed	0 $0
Q1 2022 Sep 06, 2022	SELL	$2.22 - $3.45 $64 - $100	-29 Reduced 1.41%	2,027 $6,000
Q4 2021 Jan 12, 2022	SELL	$2.36 - $3.57 $14 - $21	-6 Reduced 0.29%	2,056 $6,000
Q3 2021 Oct 06, 2021	SELL	$3.5 - $4.5 $332 - $427	-95 Reduced 4.4%	2,062 $9,000
Q2 2021 Jul 13, 2021	BUY	$3.09 - $4.54 $960 - $1,411	311 Added 16.85%	2,157 $8,000
Q1 2021 Apr 30, 2021	BUY	$3.35 - $4.93 $2,157 - $3,174	644 Added 53.58%	1,846 $6,000
Q4 2020 Jan 25, 2021	BUY	$2.35 - $3.74 $251 - $400	107 Added 9.77%	1,202 $4,000
Q1 2020 May 12, 2020	BUY	$1.27 - $3.0 $1,390 - $3,285	1,095 New	1,095 $2,000
Q4 2019 Jan 17, 2020	SELL	$1.6 - $2.43 $800 - $1,215	-500 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$1.63 - $2.62 $815 - $1,310	500 New	500 $1,000
Q1 2019 May 15, 2019	SELL	$2.0 - $2.65 $1,000 - $1,325	-500 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$2.08 - $3.36 $1,040 - $1,680	500 New	500 $1,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

355K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.37B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account